A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
NCT00672945 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 420
Last updated 2009-07-30
Summary
A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with Alzheimer's Disease receiving a stable dose of donepezil. The study consists of a 26-week double-blind treatment period.
Conditions
Interventions
- DRUG
-
PRX-03140
- DRUG
Sponsors & Collaborators
-
Epix Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2010-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01028911 ·Status: TERMINATED ·Phase: PHASE1
-
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
NCT02337907 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
NCT01862640 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
NCT00708552 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease
NCT03533257 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease
NCT01388478 ·Status: COMPLETED ·Phase: PHASE2
-
Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT03620981 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
NCT00838110 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
NCT02178124 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
NCT03548584 ·Status: COMPLETED ·Phase: PHASE3
-
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
NCT00988598 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
NCT02615002 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
NCT02695004 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
NCT00829374 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
NCT06268886 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
NCT06182085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
NCT00369785 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
NCT01922258 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
NCT00722046 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease
NCT02389413 ·Status: COMPLETED ·Phase: PHASE2
-
Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo
NCT02240693 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
NCT06702124 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
NCT03289143 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms
NCT02626572 ·Status: COMPLETED ·Phase: PHASE2